Loading company…
Trinity Biosystems develops oral therapeutic proteins and vaccines.
Founded in 2002, Trinity Biosystems develops and formulates oral therapeutic proteins. Its vaccine work covers respiratory, digestive, and sexually transmitted diseases. The company is based in Menlo Park, US, and was at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in